Good evening :)
$
₹
S

Sunshine Biopharma Inc. Warrant

SBFMW

NASDAQ
S

Sunshine Biopharma Inc. Warrant

SBFMW

NASDAQ
$0.05119.6% (+0.02)
$
₹
$0.05119.6% (+0.02)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Unknown

Sector and industry information not available

Unknown

Recent listing (market-cap unavailable as on date)

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-2.21
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-16.5%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on consolidated analysts reports

?

Buy, Sell and Hold recommendations are not available

Price Upside

—

Earnings Growth

—

Rev. Growth

+1.23%

See Detailed Forecast

Company Profile

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Forecast

Forecast

Price

Revenue

Earnings

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 1.23% growth, versus a trailing 3-year CAGR of 102.91%.

2025
Current$36.30Baseline
Forecast for Dec 2026
High$36.75+1.23%
Average$36.75+1.23%
Low$36.75+1.23%

All values in $ Million

2021202220232024202520260.224.3424.0934.8736.30Low+1.23%Average+1.23%High+1.23%
2025
Current$36.30Baseline
Forecast for Dec 2026
High$36.75+1.23%
Average$36.75+1.23%
Low$36.75+1.23%

All values in $ Million

Financials

Financials

Income

Balance Sheet

Cash Flow

9.4
-0.8
8.5
-2.1
8
-1.2
9.2
-1.5
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue7.549.308.439.598.909.419.418.578.089.26
Net Income-1.28-0.49-1.19-2.15-1.17-1.77-0.88-2.14-1.24-1.56
Net Profit Margin-17.02%-5.31%-14.20%-22.49%-13.25%-18.81%-9.38%-24.96%-15.37%-16.88%
See CostsAll values in $ Million

Peers

Price Comparison

Compare SBFMW with any stocks or ETF

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Frequently asked questions

  1. Sunshine Biopharma Inc. Warrant (SBFMW) share price today is $0.05 as of October 24, 2026 at 1:29 AM IST. The stock touched a day high of $0.00 and a day low of $0.00.

  2. Sunshine Biopharma Inc. Warrant stock trades on NASDAQ under the ticker symbol SBFMW.

  3. Sunshine Biopharma Inc. Warrant's market capitalization is N/A as of October 24, 2026 at 1:29 AM IST.

  4. Sunshine Biopharma Inc. Warrant's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. Sunshine Biopharma Inc. Warrant's price-to-book (P/B) ratio is 0 as of October 26, 2026.

  6. Yes, You can buy Sunshine Biopharma Inc. Warrant shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Sunshine Biopharma Inc. Warrant shares in three steps: 1. Search Sunshine Biopharma Inc. Warrant on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Sunshine Biopharma Inc. Warrant trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Sunshine Biopharma Inc. Warrant (SBFMW) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 182.1493 shares at the current price of $0.05.

Loading...